duodenal ulcer
Information
- Disease name
- duodenal ulcer
- Disease ID
- DOID:1724
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04702542 | Active, not recruiting | N/A | To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. | January 4, 2020 | December 30, 2028 |
| NCT00173953 | Completed | N/A | Lymphocytic Subsets and Cytokine Production With H. Pylori Infection | January 2001 | October 2001 |
| NCT00132171 | Completed | Phase 3 | Helicobacter Pylori Eradication With a New Sequential Treatment | January 2001 | December 2001 |
| NCT01964131 | Completed | Phase 1 | BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects | October 2013 | December 2013 |
| NCT02423187 | Completed | Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin | March 17, 2015 | October 30, 2017 | |
| NCT02847455 | Completed | Phase 2/Phase 3 | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients | August 2008 | |
| NCT03050359 | Completed | Phase 3 | Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection | April 5, 2017 | July 19, 2019 |
| NCT03553563 | Completed | Phase 3 | A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer | July 24, 2018 | December 27, 2022 |
| NCT05010954 | Completed | Phase 3 | Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer | October 18, 2021 | September 28, 2022 |
| NCT05208268 | Completed | A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer | July 23, 2020 | September 22, 2022 | |
| NCT00284908 | Completed | Phase 1 | Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers | September 2006 | November 2006 |
| NCT00441727 | Completed | Phase 3 | Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) | February 2007 | August 2008 |
| NCT00542789 | Completed | Phase 3 | Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID | August 2007 | February 2009 |
| NCT00543868 | Completed | Phase 2 | MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) | June 2004 | August 2004 |
| NCT00595517 | Completed | Phase 3 | Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer | October 2007 | September 2009 |
| NCT00787254 | Completed | Phase 3 | Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs | April 2007 | May 2009 |
| NCT00854451 | Completed | Phase 4 | Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection | August 1996 | February 1998 |
| NCT00952978 | Completed | Phase 3 | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) | September 2005 | May 2006 |
| NCT00953381 | Completed | Phase 2 | Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) | October 2004 | May 2005 |
| NCT01199536 | Completed | Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers | November 2010 | November 2013 | |
| NCT01435525 | Completed | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | September 2011 | March 2014 | |
| NCT01452724 | Completed | Phase 3 | Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer | October 2011 | February 2013 |
| NCT01562600 | Completed | Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation | April 19, 2012 | August 27, 2015 | |
| NCT01568385 | Completed | Phase 3 | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy | April 2012 | September 2013 |
| NCT01568398 | Completed | Phase 3 | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy | May 2012 | August 2013 |
| NCT01729182 | Completed | Nexium Capsules LDA Specific Clinical Experience Investigation | January 1, 2013 | March 9, 2017 | |
| NCT00762359 | Terminated | Phase 3 | A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers | May 2007 | November 2008 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT00197418 | Unknown status | Phase 2/Phase 3 | Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection | August 2003 | |
| NCT00149084 | Unknown status | Phase 3 | Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori | April 2003 | |
| NCT03057171 | Unknown status | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA | May 2015 | April 2020 | |
| NCT01037491 | Unknown status | N/A | Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets | October 2009 | December 2010 |
| NCT00197470 | Unknown status | N/A | Cytokine Gene Polymorphisms in Gastric Diseases | January 2000 |
- Disase is a (Disease Ontology)
- DOID:750
- Cross Reference ID (Disease Ontology)
- ICD10CM:K26
- Cross Reference ID (Disease Ontology)
- ICD9CM:532
- Cross Reference ID (Disease Ontology)
- MESH:D004381
- Cross Reference ID (Disease Ontology)
- NCI:C26755
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155691003
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:39755000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0010474
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0013295
- Exact Synonym (Disease Ontology)
- Curling Ulcer
- Exact Synonym (Disease Ontology)
- Curling's ulcers
- Exact Synonym (Disease Ontology)
- Stress Ulcer
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002588
- ICD10 preferred id (Insert disease from ICD10)
- D0008640
- ICD10 class code (Insert disease from ICD10)
- K26
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004381